NCT07146854View on ClinicalTrials.gov

EndoForce Post Approval Study

Not yet recruitingOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

November 30, 2025

Primary Completion Date

November 30, 2029

Study Completion Date

November 30, 2029

Conditions
End Stage Renal Disease (ESRD)
Trial Locations (2)

29118

MUSC Health Orangeburg, Orangeburg

29303

Spartanburg Regional Medical Center, Spartanburg

Sponsors

Lead Sponsor

Phraxis, Inc.
All Listed Sponsors
lead

Phraxis, Inc.

INDUSTRY

NCT07146854 - EndoForce Post Approval Study | Biotech Hunter | Biotech Hunter